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r P. McCarthy (Chicago, Ill). Congratulations, Dr. Ghanta, on
n excellent paper and presentation. They say that beauty is in the
ye of the beholder—and so it is with this paper from the Brigham
egarding tricuspid valve repair in patients with functional TR.
ne could say that the results of bicuspidization for TV repair are
qual to that of ring annuloplasty, but one could also say that both
re equally bad. Three years postoperatively, 3 or 4 TR was
resent still in 25% of the bicuspidization patients and 31% of the
ing patients. These are clearly not results that we would accept in
atients undergoing valve repair for a condition such as myxoma-
ous mitral regurgitation, for which we are now recommending
urgery for patients with asymptomatic disease, because the repairs
re very durable.
For some reason, we as surgeons have come to accept that a
ignificant percentage of our patients who undergo tricuspid repair
ill redevelop significant TR. While it may not always be clini-
ally significant early after surgery, increasing clinical evidence
ndicates that over time the patient will suffer for this.
I would like to note one clarification regarding your paper.
our grading of TR indicates that moderate is 3. This is consis-
ent with the STS database. Unfortunately, we have a disconnect
ith our colleagues in cardiology such that the American Society t
The Journal of Thoracicf Echo refers to 3 regurgitation as moderate to severe, and in
heir system moderate is only 2. Just to clarify for the audience,
hen, when you are referring to moderate regurgitation in this
aper, it is 3. Anytime we see a patient who redevelops 3 or 4
egurgitation, we should consider that a failure of the repair tech-
ique.
I have three questions. Your study has the usual problems with
retrospective study in that the patients treated with a ring had at
aseline lower ejection fractions and worse tricuspid regurgitation,
oth very significant risk factors for failure in our study from the
leveland Clinic. The propensity matching helps to control for this
iscrepancy. But seeing that we are mostly a group of surgeons and
ot statisticians, did there appear to be a bias towards using a ring
or worse patients, or was the use of the different techniques
imply due to surgeon preference in this group practice?
Dr Ghanta: Thank you very much, Dr. McCarthy. I agree with
ou that there is probably some bias in what type of procedure
atients may have. If they have very severe TR and are symptom-
tic, they probably were more likely to get a ring at our institution
han a bicuspidization repair. However, there was a small differ-
nce in the actual distribution of preoperative TR grades between
he two groups; the mean TR was 3.4 in the bicuspidization group
nd 3.5 in the other group. Sixty-seven percent of the patients in
he ring group had severe TR preoperatively, and 56% of the
atients had severe TR in the bicuspidization group preoperatively.
And I would agree with you that a 75% and 69% success rate
t three years may be marginally acceptable. However, it might be
etter than the alternative, which is no repair. We converted
atients who were preoperatively moderate/severe-to-severe TR to
ild TR at three years. Looking at the mortality study done by
aff and colleagues in the Journal of the American College of
ardiology, mild TR had significantly better survival in compar-
son to moderate TR as an independent risk factor. So although we
hould develop, ideally, better techniques and get better results, the
esults that we outlined here may be better than the alternative,
hich is no repair at all.
Dr McCarthy. I certainly agree with that. Also, we should be
ooking at doing earlier repairs and lower the threshold, for which
e would do a repair in this group of patients.
In our paper permanent pacing wires and ICD wires that cross
he tricuspid valve led to our highest risk for recurrence, especially
ate. By 5 years, 42% of those patients had redeveloped 3 or 4
R. Do you have any data on the use of pacemakers in your
atients, especially for the group with low ejection fractions that
hese days are treated with biventricular pacemakers, and did some
f those patients receive late pacemakers?
Dr Ghanta. None of our patients preoperatively had permanent
acemakers in place. Postoperatively, 23 (or 10%) patients re-
uired pacemakers. There was no difference between the bicus-
idization and ring annuloplasty groups in the number of patients
ho got permanent pacemakers after the operation. Six patients
eveloped a complete heart block—three in the ring and three in
he bicuspidization group.
We looked to see how many of the patients who required
acemakers developed moderate residual TR. Surprisingly, it
urned out that only 4 of those patients actually developed mod-
rate residual TR within the time period of this study. All 4 of
hose patients happened to be in the ring group, but the numbers
and Cardiovascular Surgery ● Volume 133, Number 1 125
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CDre so small that we can’t draw any meaningful conclusions behind
t. I know your study, which had 790 patients, did show that the
resence of pacemaker leads increased the risk of residual TR.
Dr McCarthy. Finally, in a follow-up study from our echo
roup, we found that tricuspid valve tethering due to a very dilated
ight ventricle was a very strong predictor for recurrent TR. This
akes sense with what we know now of mitral valve tethering
ith functional mitral regurgitation due to LV dysfunction. Do you
ave any information on other echo findings, such as right ven-
ricular dilatation, tricuspid valve tethering, RV function, and
ould you anticipate that for that group you may do a more
ggressive repair?
Dr Ghanta. Thank you. We actually do not have that infor-
ation as it is not routinely obtained in echocardiograms, but I
gree with you that it is probably very important in determining the
utcomes of tricuspid valve repair. We do need to look at the
unction of the right ventricle so that we can better determine the
ikelihood of repair being a success. Tethering may be present, and
f tethering is present it may indicate that the patient should get a
eplacement as opposed to a repair. This is something that we
ould very much like to look at in the future.
Dr H. Bolooki (Miami, Fla). Congratulations, this is a very
ice study and a fine presentation of a large number of patients. In
upport of your work, I would like to indicate that I don’t use a ring
o repair a functionally incompetent tricuspid valve. I have done
he procedure that you are describing for over 20 years. Our
echnique may be slightly different. In the very first case in early
0s we used only one suture to plicate the lateral leaflet. That did
ot work for long and within one year we had tricuspid insuffi-
iency needing urgent repair. A more complete and secure suturing
ethod that I call “triple suture, triple bite technique” was used
hereafter in all instances, which is similar to your method. The
titches follow the right lower quadrangle of the annulus from
hree o’clock to six o’clock and it works very well. It has not come
oose and has not cut through the annulus. The immediate intra-
perative echocardiogram shows minimal insufficiency, and the
ailure rate or 3 insufficiency has been less than 20% over 10
ears. Failure of the repair, however, has always followed the
ecurrence of mitral pathology.
I would like to ask, if late tricuspid insufficiency—say, 3 or
s—returns, what you do when you go back? Do you re-repair
hese, put a ring on, or change the tricuspid valve? Thank you very
uch.
Dr Ghanta. Thank you. In our group of patients we only had
who required a reoperation, and only one of those patients, or
.4%, required reoperation on the tricuspid valve. The other five
equired reoperation on the mitral valve.
We recently had a case at our hospital in which a patient had a
itral valve repair and tricuspid valve repair with a Cosgrove- i
26 The Journal of Thoracic and Cardiovascular Surgery ● Janudwards ring at an outside institution. The patient developed
ecurrent severe tricuspid regurgitation. The patient was taken to
he operating room, had the ring removed, and received a bicus-
idization annuloplasty, which eliminated the TR. This was done
ust two weeks ago. So it is possible to do reoperative procedures
sing the bicuspidization technique.
Dr D. Adams (New York, NY). I wanted to follow up on a
uestion that Dr. McCarthy asked you. That is about the mecha-
ism. It is really not residual; it is recurrent tricuspid regurgitation
n your series. Ventricular-related leaflet restriction is the most
ikely reason for that. I think a remodeling annuloplasty that really
xes the annulus is more effective for that type of mechanism, and
o you agree that the same mechanism for recurrent TR is prob-
bly right ventricular dysfunction?
The other thing that you didn’t mention and that I would like
or you to comment on is the difference in pulmonary hypertension
etween your groups, because that is obviously an important
ariable.
Finally, I would be careful trying to use operative times as a
ustification. We know Dr. Cohn is very fast, and we know which
echnique he likes to use! I believe a remodeling annuloplasty adds
bout 8 or 10 minutes to the procedure, and I think the long-term
urability may be worth it.
Thank you.
Dr Ghanta. We did not look at pulmonary pressures in this
tudy. That data was not catalogued and was not consistently
vailable in all patients, but it would be definitely worth looking at.
Dr G. Dreyfus (Middlesex, United Kingdom). I want to con-
ratulate you on your presentation; however, it seems really that
eshaping the tricuspid annulus similarly to the mitral valve does
rovide, at least in your series, similar results to this bicuspidiza-
ion technique that you show, which is more a shrinking of the
ricuspid orifice and doesn’t prevent recurrence of tricuspid regur-
itation. I think saying that both methods are showing recurrent
ricuspid regurgitation shows really how difficult it is to assess the
roper timing for surgery and that regurgitation on the right side is
ot a reliable criterion. I mean, once you have got such a tethering
f the papillary muscle, perhaps we should apply to the right side
imilar techniques that we apply to the left side. Rather than
hrinking the orifice, we should deal with the papillary muscle and
he chordae in order to try to overcome the tethering of the right
entricle. Could you comment on that?
Dr Ghanta. We definitely agree with you, and tethering of the
apillary muscle needs to be evaluated. In our study, we didn’t
ave any information regarding the papillary muscle or whether or
ot any tethering was present. But it would definitely be very
nteresting to take a look at.
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